Elliott Robinson - 26 Nov 2025 Form 4 Insider Report for Hinge Health, Inc. (HNGE)

Signature
/s/ Augie Wilkinson, Attorney-in-Fact
Issuer symbol
HNGE
Transactions as of
26 Nov 2025
Net transactions value
$0
Form type
4
Filing time
01 Dec 2025, 19:37:36 UTC
Previous filing
20 Nov 2025
Next filing
09 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Robinson Elliott Director, 10%+ Owner C/O BESSEMER VENTURE PARTNERS, 1865 PALMER AVENUE, SUITE 104, LARCHMONT /s/ Augie Wilkinson, Attorney-in-Fact 01 Dec 2025 0002058536

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HNGE Class A Common Stock Sale $0 0 $0.000000* 0 26 Nov 2025 See footnote F1, F3
transaction HNGE Class A Common Stock Sale $0 0 $0.000000* 0 28 Nov 2025 See footnote F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 26, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 103,160 and 96,840 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $50.5040. These shares were sold in multiple transactions at prices ranging from $50.00 to $51.35. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 On November 28, 2025, BVP X and BVP X Inst sold 23,176 and 21,757 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $50.1555. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.